| Literature DB >> 18799310 |
Snahel D Patel1, Wendy M Habeski, Hyunsuk Min, Jiansu Zhang, Robin Roof, Bradley Snyder, Gary Bora, Brian Campbell, Cheryl Li, Debra Hidayetoglu, Douglas S Johnson, Archana Chaudhry, Maura E Charlton, Natasha M Kablaoui.
Abstract
The discovery of the CNS-penetrant and selective alpha(2C) adrenergic receptor antagonist N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, 13 is described. Structure-activity studies demonstrate the structural requirements for binding affinity, functional activity, and selectivity over other alpha(2)-AR subtypes.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18799310 DOI: 10.1016/j.bmcl.2008.08.055
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823